Skip to main content
JIN YANG PHARMACEUTICAL. CO., LTD logo

JIN YANG PHARMACEUTICAL. CO., LTD — Investor Relations & Filings

Ticker · 007370 ISIN · KR7007370000 KO Manufacturing
Open in API
Filings indexed 210 across all filing types
Latest filing 2022-03-23 Declaration of Voting R…
Country KR South Korea
Listing KO 007370

About JIN YANG PHARMACEUTICAL. CO., LTD

https://www.jinyangpharm.com/

JIN YANG PHARMACEUTICAL. CO., LTD. is a company engaged in the research, development, manufacturing, and sale of pharmaceutical products, with a primary focus on prescription drugs. The company operates a fully automated, high-tech manufacturing facility. Its research and development efforts are dedicated to creating advanced preventive and therapeutic treatments for various diseases. Key areas of R&D include the development of anticancer drugs through molecular biology research, particularly for leukemia, and therapies for metabolic disorders such as diabetes and obesity. The company also develops antivirals and explores formulations based on herbal preparations.

Recent filings

Filing Released Lang Actions
정기주주총회결과
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is an official report of the results of a General Meeting of Shareholders (정기주주총회결과). It details the outcomes of voting on agenda items such as financial statement approval, dividend declarations, election of directors, and changes to business purposes. This falls under the category of Declaration of Voting Results & Voting Rights Announcements.
2022-03-23 Korean
사외이사의선임ㆍ해임또는중도퇴임에관한신고
Board/Management Information Classification · 100% confidence The document is a regulatory filing from Jinyang Pharmaceutical Co., Ltd. regarding the appointment of an outside director (사외이사). It follows the standard format for reporting changes in board composition to the Financial Services Commission/Korea Exchange. Since it specifically announces the appointment of a board member, it falls under the 'Board/Management Information' category.
2022-03-23 Korean
감사보고서제출
Audit Report / Information Classification · 100% confidence The document is a regulatory filing from Jinyang Pharmaceutical titled 'Audit Report Submission' (감사보고서 제출). It provides a summary of the audit opinion (unqualified/proper), key financial data (assets, liabilities, revenue, profit), and auditor information. According to the 'Menu vs Meal' rule, this is a short announcement (under 5,000 characters) notifying the public that the audit report has been submitted to the regulatory body. While it contains financial data, it is a formal notification of the audit report filing rather than the full annual report itself. Therefore, it is classified as a Report Publication Announcement (RPA). FY 2021
2022-03-15 Korean
사업보고서 (2021.12)
Audit Report / Information Classification · 100% confidence The document is a comprehensive 'Audit Report' (감사보고서) for Jinyang Pharmaceutical Co., Ltd. for the fiscal year 2021. It includes the independent auditor's report from Samil PricewaterhouseCoopers, detailed financial statements (Statement of Financial Position, Statement of Comprehensive Income, Statement of Changes in Equity, Statement of Cash Flows), and extensive notes to the financial statements. While it contains financial data, it is a formal audit report rather than a standalone annual report (10-K) or a simple earnings release. Given the specific category 'Audit Report / Information' (AR) exists, this is the most accurate classification. FY 2021
2022-03-15 Korean
[기재정정]주주총회소집공고
AGM Information Classification · 98% confidence The document is a 'Correction Report' (정정신고) for a 'Notice of Convocation of General Meeting of Shareholders' (주주총회소집공고). It contains detailed financial statements (Balance Sheet, Income Statement, Statement of Changes in Equity, Cash Flow Statement) as part of the management reference materials for the upcoming AGM. Since the document is a formal filing related to the materials and agenda for an Annual General Meeting, it falls under the AGM Information category.
2022-03-10 Korean
[기재정정]의결권대리행사권유참고서류
Proxy Solicitation & Information Statement Classification · 100% confidence The document is titled '의결권대리행사권유참고서류' (Proxy Solicitation Reference Document) and is a '정정신고' (Correction Filing). It contains detailed financial statements (Balance Sheet, Income Statement, Statement of Changes in Equity, Cash Flow Statement) for the 44th and 43rd fiscal periods, which are being provided as part of the materials for a shareholder meeting. While it contains financial data, its primary purpose is to serve as a proxy solicitation document for shareholders to exercise their voting rights at the upcoming Annual General Meeting. Therefore, it is classified as a Proxy Solicitation & Information Statement.
2022-03-10 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.